Literature DB >> 8815938

Clinical and genetic abnormalities in patients with Friedreich's ataxia.

A Dürr1, M Cossee, Y Agid, V Campuzano, C Mignard, C Penet, J L Mandel, A Brice, M Koenig.   

Abstract

BACKGROUND: Friedreich's ataxia, the most common inherited ataxia, is associated with a mutation that consists of an unstable expansion of GAA repeats in the first intron of the frataxin gene on chromosome 9, which encodes a protein of unknown function.
METHODS: We studied 187 patients with autosomal recessive ataxia, determined the size of the GAA expansions, and analyzed the clinical manifestations in relation to the number of GAA repeats and the duration of disease.
RESULTS: One hundred forty of the 187 patients, with ages at onset ranging from 2 to 51 years, were homozygous for a GAA expansion that had 120 to 1700 repeats of the trinucleotides. About one quarter of the patients, despite being homozygous, had atypical Friedreich's ataxia; they were older at presentation and had intact tendon reflexes. Larger GAA expansions correlated with earlier age at onset and shorter times to loss of ambulation. The size of the GAA expansions (and particularly that of the smaller of each pair) was associated with the frequency of cardiomyopathy and loss of reflexes in the upper limbs. The GAA repeats were unstable during transmission.
CONCLUSIONS: The clinical spectrum of Friedreich's ataxia is broader than previously recognized, and the direct molecular test for the GAA expansion on chromosome 9 is useful for diagnosis, determination of prognosis, and genetic counseling.

Entities:  

Mesh:

Year:  1996        PMID: 8815938     DOI: 10.1056/NEJM199610173351601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  265 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  Epigenetics in nucleotide repeat expansion disorders.

Authors:  Fang He; Peter K Todd
Journal:  Semin Neurol       Date:  2012-01-21       Impact factor: 3.420

3.  Longitudinal change in dysarthria associated with Friedreich ataxia: a potential clinical endpoint.

Authors:  Kristin M Rosen; Joanne E Folker; Adam P Vogel; Louise A Corben; Bruce E Murdoch; Martin B Delatycki
Journal:  J Neurol       Date:  2012-06-06       Impact factor: 4.849

Review 4.  [Clinical details and genetics of recessive ataxias].

Authors:  C Zühlke; F Kreuz; K Bürk
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

5.  Has Progress Been Made in Progressive Myoclonic Epilepsy (EPM1)?

Authors:  M Scott Perry
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

Review 6.  Emerging therapies in Friedreich's ataxia.

Authors:  Tanya V Aranca; Tracy M Jones; Jessica D Shaw; Joseph S Staffetti; Tetsuo Ashizawa; Sheng-Han Kuo; Brent L Fogel; George R Wilmot; Susan L Perlman; Chiadi U Onyike; Sarah H Ying; Theresa A Zesiewicz
Journal:  Neurodegener Dis Manag       Date:  2016

7.  Nonneurological Involvement in Late-Onset Friedreich Ataxia (LOFA): Exploring the Phenotypes.

Authors:  Alberto R M Martinez; Adriana Moro; Agessandro Abrahao; Ingrid Faber; Conrado R Borges; Thiago J R Rezende; Carlos R Martins; Mariana Moscovich; Renato P Munhoz; Sandra Leistner Segal; Walter O Arruda; Maria Luiza Saraiva-Pereira; Simone Karuta; José Luiz Pedroso; Anelyssa D'Abreu; Laura B Jardim; Íscia Lopes-Cendes; Orlando G Barsottini; Hélio A G Teive; Marcondes C França
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

8.  Movement disorders: Friedreich ataxia today—preparing for the final battle.

Authors:  Giuseppe De Michele; Alessandro Filla
Journal:  Nat Rev Neurol       Date:  2015-03-10       Impact factor: 42.937

9.  Kidney infarction in Friedreich's ataxia with dilated cardiomyopathy.

Authors:  Dimitrios Stergios Evangelopoulos; Tatiana Nataly Pirvu; Aristomenis Exadaktylos; Sandro Kohl
Journal:  BMJ Case Rep       Date:  2012-09-30

Review 10.  Pharmacological treatments for Friedreich ataxia.

Authors:  Mary Kearney; Richard W Orrell; Michael Fahey; Ruth Brassington; Massimo Pandolfo
Journal:  Cochrane Database Syst Rev       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.